Yunnan Botanee Bio-technology Group Co., Ltd. Class A · SZSE:300957
Yunnan Botanee Bio-technology Group Co., Ltd. Class A — FY2023 and Q1 2024 Earnings Presentation
37 slides from Yunnan Botanee Bio-technology Group Co., Ltd. Class A's earnings presentation, 2024
Slide 1: 2023 Performance Review & 24Q1 Performance Update
2023 Performance Review & 24Q1 Performance Update
Slide 2: Highlights
Highlights BTN recorded resilient revenue performance. In 2023, our annual revenue reached RMB 5.52 billion, up 10.1% YoY; in 24Q1, the quarterly revenue hit RMB 1.10 billion, up 27.1% compared to 23Q1. BTN’s main brands recorded steady revenue growth, while sub-brands gained momentum. WINONA Baby r
Slide 3: Contents
Contents FINANCIAL BUSINESS STRATEGIC RESULTS REVIEW OUTLOOK
Slide 4: Financial Results
BINSS£82 BOTANEE GROUP AERA : 300957.SZ FINANCIAL RESULTS
Slide 5: Continued strong momentum, decreasing reliance on major sales promotion campaigns
Continued strong momentum, decreasing reliance on major sales promotion campaigns Revenue (in RMB 100 million) Quarterly Revenue in 2023 (in RMB Q4 to the annual income has 100 million) and Proportion (%) continued to decline.（%） 60 50% 47.5% +10.1% 55.2 50.1 45% 42.3% 50 40% 37.9% Q1; 8.6; 40 35% 1
Slide 6: Decreased reliance on online channels, remarkable contributions from offline sales
Decreased reliance on online channels, remarkable contributions from offline sales Revenue by Channel (in RMB 100 million) Revenue Distribution by Channel (%) 40 35.7 35.5 35 2023 30 Offline Sales 25.9% 2022 25 Offline Sales 19.2% 20 +48.9% 2022 14.3 Private 15 2023 2022, channels… Private Online Sa
Slide 7: Sales revenue grows remarkably on Douyin, while OTC channels contribute increasing sales
Sales revenue grows remarkably on Douyin, while OTC channels contribute increasing sales Revenue by Online Channel (in RMB Revenue by Online Channel (in RMB 100 million) 100million) 9 66.1% 70% 8.2 25 60% 8 60% 20.6 50% 7 47.1% 6.1 20 50% 17.6 40% 6 5.2 4.9 40% 5 4.7 4.7 30% 15 20% 4 30.8% 30% 14.3%
Slide 8: Maintained high R&D expenses with slight structural increment in marketing expenses
With a long-term competitive edge fortified by intensified R&D efforts, BTN engages in cross-sectoral marketing, with a slight structural increment in marketing expenses Maintained High R&D Expenses A Slight Structural Increment in Marketing (in RMB 1 million) Expenses (in RMB 100 million) 310 5.4%
Slide 9: Safeguarding shareholder interests: planned dividend and cumulative buyback
Safeguarding shareholder interests, a planned dividend of 252 million yuan with cumulative buyback exceeding 200 million yuan in 2023 Net Profit Attributable to Parent (in RMB 100 Dividend Payout million) and Net Profit Margin (%) 12 25% 0.9 400 10.5 0.80 0.8 350 10 21.0% 338.9 20% 0.7 18.3% 300 -28
Slide 10: Business Review
BTN corinét ocr BT SZ, RAAB : BUSINESS REVIEW
Slide 11: Brand Matrix Overview: Narrowing the focus and widening the path
Brand Matrix Overview: Narrowing the focus and widening the path, BTN continues to expand its brand matrix • At BTN, product development follows the EBM approach. From care for sensitive skin to devoted research for sensitive skin, we have established four distinct brands with well-defined positioni
Slide 12: BTN intensifies R&D efforts to build long-term competitive edge
Strategic Vision & Steady Growth: BTN intensifies R&D efforts to build long-term competitive edge WINONA Red Book 3.0 Officially Released R&D • WINONA Red Book 3.0 • During the reporting period, BTN maintained high R&D WINONA Red Book 2.0 • 16 national expert expenses, which grew 17.3% compared to t
Slide 13: Stages of Formula Research
Backed by the EBM approach and pioneering research, BTN remains committed to industry-university-research integration New Technologies: New Ingredients: Our new seepage technology reduces Prinsepia Utilis Royle crosslinking through microfluidics, Polysaccharide enhances enabling effective penetratio
Slide 14: Product Innovation: Expanding product reach with R&D
Product Innovation: Expanding product reach with R&D Product R&D Center Skin Health Institute Ingredient Department Registration & Filing Pre-project Research Ingredient Screening Consumer Research Filing/Declaration Department Research Product Evaluation Human Efficacy Evaluation Transformation Dep
Slide 15: Mid-stage Organizations: A business-driven center
Mid-stage Organizations: A business-driven center for breaking functional boundaries between front-stage and mid-stage operations • Focus: Reshaping Value + Expanding Product Offerings + Leveraging Marketing Channels • We have introduced the BTN Data Mid-stage System to enhance our digital capabilit
Slide 16: Innovative Marketing: cross-sectoral promotions
Innovative Marketing: BTN fosters a positive influence and associate brandswith culture for cross-sectoral promotions My wrinkles are the stories of my past. Ingredient Traceability Documentary We have treated millions of sensitive skin You can choose to embrace the tiny flaws of your skin or concer
Slide 17: Online Channels: Tmall and Douyin
Online Channels: With a steady presence on Tmall and a marketing emphasis on Douyin, BTN continues to shape the user mindset Sales volume ranked 5th on Tmall during the Double 11 Sales record ranked 9th on Douyin during the Double 11 Increase in repeat purchase rates for online Shopping Festival, as
Slide 18: Offline Channels: OTC transformation
Offline Channels: BTN is leading an OTC transformation while expanding marketing channels and attracting new members • “Retail Pharmacy Beauty & Health+”: BTN has partnered with over 89,000 OTC pharmacies, with sales reaching RMB 816 million in 2023, up 66.1% YoY. • In 2023, BTN launched the “Skin M
Slide 19: WINONA Baby registered record-high revenue
WINONA Baby registered record-high revenue with professional stage-specific skincare Professional stage-specific skincare Online omnichannel Young kids (over 3 years Infants (0-3 years old): Bestsellers marketing Addresses skin barrier old): As the skin growth functions and hydration stabilizes, our
Slide 20: A rising star with an accolade of honors
A rising star with an accolade of honors 「A strong brand recognized by prestigious awards」 「Baby Academic Forum」 WINONA Baby, in collaboration with the Dermatology Committee of the Chinese Association for Improving Birth Outcome and Child Development, hosted the “Child Skin Health Promotion in China
Slide 21: AOXMED gathers momentum with high-tech solutions
AOXMED gathers momentum with high-tech solutions Botanee International Skin Health Summit: Expertise in Medical Beauty Expertise in Home Beauty AOXMED International Skin Rejuvenation Summit Medical Beauty accounts for 60% of AOXMED’s sales from Medical Beauty accounts for 40% of AOXMED’s sales from
Slide 22: Beforteen pioneers AI applications in skin health
Beforteen pioneers AI applications in skin health Beforteen, following the strategy of “precision acne treatment and graded solutions”, integrates diagnosis and treatment, providing “medicine + cosmetics + diet” treatment plans for acne-prone populations aged 18-30. Beforteen’s unique advantages AI
Slide 23: Za: New products with post-investment empowerment from BTN
Za: With post-investment empowerment from BTN, Za launches new products to meet the public demand for beauty products and skincare solutions. Bestseller Upgrade: The Fifth Za and BTN co-founded the Generation Za Makeup Base Celebrating 20 years of success with [A New Hit!] Shanghai Joint Laboratory
Slide 24: Pure & Mild: Introducing new products with R&D empowerment
Pure & Mild: Introducing new products with R&D empowerment • Pure & Mild X BTN Joint Anti-aging Laboratory: The lab not only inherits Pure & Mild’s over 20 years of expertise in plant-based skincare products but also leverages the research prowess of BTN. The joint laboratory currently has over 60 s
Slide 25: ESG: Integrity is key, steady operations the cornerstone
ESG: Integrity is key, while steady operations serve as the cornerstone • BTN takes its obligation to disclose information for • BTN consistently complies with relevant regulations and conducts its business operations in accordance with the listed companies seriously, ensuring shareholders' law. We
Slide 26: ESG: Green, low-carbon, circular development
ESG: Green, low-carbon, circular development drives new quality productive forces for enterprises • BTN's central factory, officially put into operation in 2023, sits within Kunming High-tech Industrial Development Zone in Yunnan Province. Spanning 53,333 m2 with a total construction area of 59,000
Slide 27: ESG: Prinsepia Utilis Royle tracing and biodiversity conservation in Mount Haba
ESG: From source tracing of the Prinsepia Utilis Royle to biodiversity conservation in Mount Haba • BTN views sustainable development as an opportunity and is committed to protecting biodiversity and upholding principles to create a brighter future. • Located in Yunnan, BTN has set up the Prinsepia
Slide 28: ESG: BTN fulfills social responsibility
ESG: BTN fulfills social responsibility, and practices business for a good cause In 2021, the Yunnan Project Hope established its inaugural special public welfare fund, focusing on initiatives for ecological environmental protection, with a specific emphasis on engaging adolescents in biodiversity
Slide 29: Strategic Outlook
BINSS£82 BOTANEE GROUP RRB : 300957. “SZ STRATEGIC OUTLOOK
Slide 30: A Deep Dive Into Dermatological Beauty
A Deep Dive Into Dermotological Beauty Trend Analysis of Sensitive- China’s Cosmetics Consumption skin User Demands Market Volume in 2024 WINONA continues to dominate the Chinese dermatology market as the top brand. User Mindset Anti- aging Anti- allergy Most registered repair products Anti-glycatio
Slide 31: WINONA 2.0: Strengthen brand competitiveness
WINONA 2.0: Strengthen brand competitiveness, reinforce user recognition, and target market penetration WINONA 2.0 Era: With a focus on sensitive skin, we recover the beauty of healthy skin Formula Technology 2.0 • We target the needs of sensitive Sensitive Skincare 2.0 Dermatology 2.0 Plant Technol
Slide 32: Strengthening the foundation and steadily moving forward
Strengthening the foundation, delving into the source, and steadily moving forward are key to long-term success. Upgrade the Incubate new brands of the Streamline product lines for Enhance offline channel primary brand ecological chain and effective price control penetration and delve into upgrade a
Slide 33: Expand overseas business and establish a global research network
Expand overseas business and establish a global research network Swiss Research Center (Geneva) Botanee Research Botanee Research Institute (Shanghai) Institute (Shanghai) Efficacy Cosmetic Research Center, Innovative Material Research France R&D Center (Paris) Center,Medical Device Research Departm
Slide 34: Investment and M&A: Rooted in the BTN ecosystem
Investment and M&A: Rooted in the BTN’s ecosystem and engaging in the expansive realms of health and beauty. An Exciting Future with Mutual Benefits Horizontal expansion: We venture into the exciting new trillion-dollar beauty prospects in beauty and and personal care wellness beyond conventional ma
Slide 35: Appendix: Shareholding Structure
Appendix: Shareholding Structure GUO ZHENYU KEVIN GUO 70.00% 30.00% Hanson Cosmeceutical Company Limited 100.00% Hanson Cosmeceutical (Hong Kong)Company Limited Beyond China’s Mainland (Incl. Hong Kong, Macao, and Taiwan) 51.00% 100.00% In China’s Mainland (Excl. Hong Kong, Macao, and Taiwan) Yunnan
Slide 36: Statement
S t a t e me n t This document has been prepared by Yunnan Botanee Biotech Group Co., Ltd. ("BTN") solely for use in BTN's 2023 annual and 2024 first-quarter roadshows. Any public dissemination, reproduction, sharing, or distribution of this material, in whole or in part, to any other person is stri
Slide 37: Q&A Thank you for watching
Q&A THANK YOU FOR WATCHING ir@botanee.com 968 Jinzhong Rd, Changning District, Shanghai https://www.botanee.com.cn
Yunnan Botanee Bio-technology Group — FY2023 and Q1 2024 Earnings Presentation on 6ix